blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3524237

EP3524237 - REPURPOSING COMPOUNDS FOR THE TREATMENT OF INFECTIONS AND FOR MODULATING THE COMPOSITION OF THE GUT MICROBIOME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.07.2020
Database last updated on 28.06.2024
FormerThe application has been published
Status updated on  12.07.2019
Most recent event   Tooltip03.07.2020Application deemed to be withdrawnpublished on 05.08.2020  [2020/32]
Applicant(s)For all designated states
European Molecular Biology Laboratory
Meyerhofstrasse 1
69117 Heidelberg / DE
[2019/33]
Inventor(s)01 / PRUTEANU, Mihaela
Krumme Strasse 2
10585 Berlin / DE
02 / MAIER, Lisa
Karlsruherstrasse 108
69126 Heidelberg / DE
03 / KUHN, Michael
Hardtstrasse 54
69126 Heidelberg / DE
04 / BORK, Peer
Meyerhofstrasse 1
69117 Heidelberg / DE
05 / TYPAS, Athanasios
Werderstrasse 54
69120 Heidelberg / DE
06 / PATIL, Kiran Raosaheb
Gustav-Kirchhoff-Strasse 7/1
69120 Heidelberg / DE
07 / ZELLER, Georg
Kaiserstrasse 66
69115 Heidelberg / DE
 [2019/33]
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2019/33]
Application number, filing date18156520.113.02.2018
[2019/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3524237
Date:14.08.2019
Language:EN
[2019/33]
Search report(s)(Supplementary) European search report - dispatched on:EP02.11.2018
ClassificationIPC:A61K31/137, A61K31/4422, A61P31/04
[2019/33]
CPC:
A61K31/4422 (EP,US); A61K31/137 (EP,US); Y02A50/30 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/33]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:UMNUTZUNG VON VERBINDUNGEN ZUR BEHANDLUNG VON INFEKTIONEN UND ZUR MODULIERUNG DER ZUSAMMENSETZUNG DES DARMMIKROBIOMS[2019/33]
English:REPURPOSING COMPOUNDS FOR THE TREATMENT OF INFECTIONS AND FOR MODULATING THE COMPOSITION OF THE GUT MICROBIOME[2019/33]
French:RÉORIENTATION DE COMPOSÉS POUR LE TRAITEMENT D'INFECTIONS ET LA MODULATION DE LA COMPOSITION DU MICROBIOME INTESTINAL[2019/33]
Examination procedure15.02.2020Application deemed to be withdrawn, date of legal effect  [2020/32]
10.03.2020Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2020/32]
Fees paidPenalty fee
Additional fee for renewal fee
29.02.202003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2010026602  (ICGEB [IN], et al) [X] 1-6,8,12,14,15 * page 1, lines 5-12 * * page 7, lines 5-7 * * claims 1-4 *;
 [XI]CN102068437  (XIAOXI ZHUANG) [X] 1,2,5,6,8,12,15 * the whole document * [I] 3,4,14;
 [A]WO2015017402  (UNIV NEBRASKA [US]) [A] 1-8,11-15* claims 1, 3, 11, 12 *;
 [XI]  - A. DASGUPTA ET AL, "Studies on the antimicrobial potential of the cardiovascular drug lacidipine", IN VIVO, (2007), vol. 21, pages 847 - 850, XP002783140 [X] 1,2,5,6,8,12,13,15 * page 849; table 1 * [I] 3,4,14
 [XI]  - MAZUMDAR K ET AL, "Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, ELSEVIER, AMSTERDAM, NL, vol. 36, no. 4, ISSN 0924-8579, (20101001), pages 295 - 302, (20100629), XP027230486 [X] 1,2,5,6,8,12,13,15 * page 298; table 1 * * page 299, column 1, paragraph 3 - column 2, paragraph 2 * [I] 3,4,14
by applicantWO2005025507
 US2017065540
    - YOUNIS et al., "Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens", Current Pharmaceutical Design, (20170000), vol. 23, pages 1 - 11
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.